Format

Send to

Choose Destination
Nat Rev Neurol. 2017 Oct;13(10):573-574. doi: 10.1038/nrneurol.2017.119. Epub 2017 Sep 8.

Cladribine - an old newcomer for pulsed immune reconstitution in MS.

Author information

1
Department of Neurology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany.

Abstract

The EMA has approved cladribine tablets for the treatment of multiple sclerosis. The drug is not new, and the journey to its approval has been a long one, but the old concepts that cladribine therapy are based on provide a new option for the possibility of drug-free remission.

PMID:
28884753
DOI:
10.1038/nrneurol.2017.119
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center